Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 28 (ZNF28) is a member of the zinc finger protein family, characterized by the presence of zinc finger motifs that coordinate zinc ions and stabilize the protein structure. Members of the zinc finger protein family usually function as transcription factors, binding to DNA and helping regulate gene expression by RNA polymerase II. ZNF28 is predicted to localize to the nucleus and to play a role in transcriptional regulation, but its specific molecular function, target genes, and physiological roles remain poorly characterized. ZNF28 is not currently classified as a direct therapeutic target, and there are no drugs or specific disease associations definitively linked to this gene. The protein is encoded on chromosome 19 and has several known aliases, reflecting prior gene nomenclature. As with other zinc finger proteins, ZNF28 may contribute to fundamental cellular processes through gene regulation but individual biological or disease associations are unconfirmed to date.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 28 (ZNF28).